Literature DB >> 12859878

[Detection of 29 types of fusion gene in leukemia by multiplex RT-PCR].

Zhi-gang Li1, Min-yuan Wu, Wei Zhao, Bin Li, Jing Yang, Ping Zhu, Ya-mei Hu.   

Abstract

OBJECTIVE: To analyze the fusion genes derived from 29 types of chromosome structural aberrations in children with leukemia.
METHODS: Bone marrow samples from 191 children with leukemia were analyzed with a novel multiplex nested RT-PCR.
RESULTS: Of the 191 leukemic samples, 86 (45.0%) carried 14 types of fusion genes including SIL/TAL1, MLL/AF1q, E2A/PBX1, MLL/AF6, AML1/ETO, MLL/AF9, TEL/ABL, BCR/ABL, MLL/AF10, dupMLL, MLL/ENL, TEL/AML1, PML/RARalpha and CBFbeta/MYH11. The activation of oncogene HOX11 was detected in 31 cases, with or without other chromosome aberrations in 15 (7.8%) and 16 cases (8.4%), respectively.
CONCLUSION: This multiplex nested RT-PCR reaction could screen 29 types of chromosome structural aberrations at the same time. It may be helpful for the detection of minimal residual diseases after chemotherapy and bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12859878

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  3 in total

1.  Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 chromosomal translocation in hematologic malignancies.

Authors:  Mei Huang; Chunrui Li; Huang Liang; Jianfeng Zhou; Jinniu Deng; Wenli Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

2.  Gene mining: a novel and powerful ensemble decision approach to hunting for disease genes using microarray expression profiling.

Authors:  Xia Li; Shaoqi Rao; Yadong Wang; Binsheng Gong
Journal:  Nucleic Acids Res       Date:  2004-05-17       Impact factor: 16.971

3.  Distribution of fusion transcripts and its clinical impact in patients with acute myeloid leukemia in Sudan.

Authors:  Abdel Rahim Mahmoud Muddathir; Tarig A M Hamid; Elwaleed M Elamin; Omar F Khabour
Journal:  Int J Health Sci (Qassim)       Date:  2021 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.